LakeShore Biopharma Co. L... (LSB)
2.60
0.00 (0.00%)
At close: Jan 15, 2025, 10:20 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY24 | FY23 | FY22 | FY21 |
| Revenue | 573.42M | 687.20M | 502.95M | 257.02M |
| Cost of Revenue | 117.69M | 153.36M | 117.07M | 59.66M |
| Gross Profit | 455.73M | 533.84M | 385.88M | 197.36M |
| Operating Income | -445.83M | -139.38M | -549.18K | -125.85M |
| Interest Income | n/a | n/a | n/a | n/a |
| Pretax Income | -455.19M | -144.35M | -545.73K | -174.37M |
| Net Income | -433.46M | -145.48M | -545.73K | -191.83M |
| Selling & General & Admin | 428.09M | 333.32M | 549.18K | 208.33M |
| Research & Development | 302.80M | 318.70M | 211.22M | 94.39M |
| Other Expenses | 170.67M | -199.45K | -2.41M | -22.36M |
| Operating Expenses | 901.56M | 647.15M | 549.18K | 319.68M |
| Interest Expense | 44.34M | 30.86M | 2.72M | 29.69M |
| Selling & Marketing Expenses | 280.45M | 251.56M | 165.72M | 69.44M |
| Cost & Expenses | 1.02B | 800.51M | 549.18K | 379.33M |
| Income Tax | -21.73M | 1.13M | 4.94M | 17.45M |
| Shares Outstanding (Basic) | 106.92M | 77.42M | 29.50M | 28.75M |
| Shares Outstanding (Diluted) | 106.92M | 77.42M | 29.50M | 28.75M |
| EPS (Basic) | -4.05 | -1.88 | -0.02 | -6.67 |
| EPS (Diluted) | -4.05 | -1.88 | -0.02 | -6.67 |
| EBITDA | -368.66M | -76.80M | -67.20M | -116.78M |
| Depreciation & Amortization | 42.19M | 36.69M | 31.15M | 27.91M |